1
|
Ammi M, Arpin E, Dedewanou FA, Allin S. Do expenditures on public health reduce preventable mortality in the long run? Evidence from the Canadian provinces. Soc Sci Med 2024; 345:116696. [PMID: 38377835 DOI: 10.1016/j.socscimed.2024.116696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2023] [Revised: 01/19/2024] [Accepted: 02/13/2024] [Indexed: 02/22/2024]
Abstract
BACKGROUND Investments in public health - prevention of illnesses, and promotion, surveillance, and protection of population health - may improve population health, however, effects may only be observed over a long period of time. OBJECTIVE To investigate the potential long-run relationship between expenditures on public health and avoidable mortality from preventable causes. METHODS We focused on the country spending the most on public health in the OECD, Canada. We constructed a longitudinal dataset on mortality, health care expenditures and socio-demographic information covering years 1979-2017 for the ten Canadian provinces. We estimated error correction models for panel data to disentangle short-from long-run relationships between expenditures on public health and avoidable mortality from preventable causes. We further explored some specific causes of mortality to understand potential drivers. For comparison, we also estimated the short-run relationship between curative expenditures and avoidable mortality from treatable causes. RESULTS We find evidence of a long-run relationship between expenditures on public health and preventable mortality, and no consistent short-run associations between these two variables. Findings suggest that a 1% increase in expenditures on public health could lead to 0.22% decrease in preventable mortality. Reductions in preventable mortality are greater for males (-0.29%) compared to females (-0.09%). These results are robust to different specifications. Reductions in some cancer and cardiovascular deaths are among the probable drivers of this overall decrease. By contrast, we do not find evidence of a consistent short-run relationship between curative expenditures and treatable mortality, except for males. CONCLUSION This study supports the argument that expenditures on public health reap health benefits primarily in the long run, which, in this case, represents a reduction in avoidable mortality from preventable causes. Reducing public health expenditures on the premise that they have no immediate measurable benefits might thus harm population health outcomes in the long run.
Collapse
Affiliation(s)
- Mehdi Ammi
- School of Public Policy and Administration, Carleton University, Richcraft Hall, 1125 Colonel By Dr, Ottawa, ON, K1S 5B6, Canada; Centre for the Business and Economics of Health, University of Queensland, Sir Llew Edwards Building, St Lucia, QLD, 4072, Australia.
| | - Emmanuelle Arpin
- Institute of Health Policy Management and Evaluation, University of Toronto, 155 College St 4th Floor, Toronto, ON, M5T 3M6, Canada
| | - F Antoine Dedewanou
- School of Public Policy and Administration, Carleton University, Richcraft Hall, 1125 Colonel By Dr, Ottawa, ON, K1S 5B6, Canada
| | - Sara Allin
- Institute of Health Policy Management and Evaluation, University of Toronto, 155 College St 4th Floor, Toronto, ON, M5T 3M6, Canada
| |
Collapse
|
2
|
Gloria MAJ, Thavorncharoensap M, Chaikledkaew U, Youngkong S, Thakkinstian A, Chaiyakunapruk N, Ochalek J, Culyer AJ. Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds. Expert Rev Pharmacoecon Outcomes Res 2024; 24:203-215. [PMID: 38112068 DOI: 10.1080/14737167.2023.2296562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2023] [Accepted: 12/14/2023] [Indexed: 12/20/2023]
Abstract
OBJECTIVE Empirical estimates of the impact of healthcare expenditure on health outcome measures may inform the cost-effectiveness threshold (CET) for guiding funding decisions. This study aims to systematically review studies that estimated this, summarize and compare the estimates by country income level. METHODS We searched PubMed, Scopus, York Research database, and [anonymized] for Reviews and Dissemination database from inception to 1 August 2023. For inclusion, a study had to be an original article, estimating the impact of healthcare expenditure on health outcome measures at a country level, and presented estimates, in terms of cost per quality-adjusted life year (QALY) or disability-adjusted life year (DALY). RESULTS We included 18 studies with 385 estimates. The median (range) estimates were PPP$ 11,224 (PPP$ 223 - PPP$ 288,816) per QALY gained and PPP$ 5,963 (PPP$ 71 - PPP$ 165,629) per DALY averted. As ratios of Gross Domestic Product per capita (GDPPC), these estimates were 0.376 (0.041-182.840) and 0.318 (0.004-37.315) times of GDPPC, respectively. CONCLUSIONS The commonly used CET of GDPPC seems to be too high for all countries, but especially low-to-middle-income countries where the potential health losses from misallocation of the same money are greater. REGISTRATION The review protocol was published and registered in PROSPERO (CRD42020147276).
Collapse
Affiliation(s)
- Mac Ardy Junio Gloria
- Mahidol University Health Technology Assessment Graduate Program, Mahidol University, Bangkok, Thailand
- Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila, Manila, Philippines
| | - Montarat Thavorncharoensap
- Mahidol University Health Technology Assessment Graduate Program, Mahidol University, Bangkok, Thailand
- Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
| | - Usa Chaikledkaew
- Mahidol University Health Technology Assessment Graduate Program, Mahidol University, Bangkok, Thailand
- Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
| | - Sitaporn Youngkong
- Mahidol University Health Technology Assessment Graduate Program, Mahidol University, Bangkok, Thailand
- Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
| | - Ammarin Thakkinstian
- Mahidol University Health Technology Assessment Graduate Program, Mahidol University, Bangkok, Thailand
- Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Nathorn Chaiyakunapruk
- Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA
- IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA
| | | | | |
Collapse
|
3
|
Zimmer Z, Zajacova A, Fraser K, Powers D, Grol-Prokopczyk H. A global comparative study of wealth-pain gradients: Investigating individual- and country-level associations. DIALOGUES IN HEALTH 2023; 2:100122. [PMID: 38099153 PMCID: PMC10718570 DOI: 10.1016/j.dialog.2023.100122] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2022] [Revised: 01/27/2023] [Accepted: 03/05/2023] [Indexed: 12/17/2023]
Abstract
Pain is a significant yet underappreciated dimension of population health. Its associations with individual- and country-level wealth are not well characterized using global data. We estimate both individual- and country-level wealth inequalities in pain in 51 countries by combining data from the World Health Organization's World Health Survey with country-level contextual data. Our research concentrates on three questions: 1) Are inequalities in pain by individual-level wealth observed in countries worldwide? 2) Does country-level wealth also relate to pain prevalence? 3) Can variations in pain reporting also be explained by country-level contextual factors, such as income inequality? Analytical steps include logistic regressions conducted for separate countries, and multilevel models with random wealth slopes and resultant predicted probabilities using a dataset that pools information across countries. Findings show individual-level wealth negatively predicts pain almost universally, but the association strength differs across countries. Country-level contextual factors do not explain away these associations. Pain is generally less prevalent in wealthier countries, but the exact nature of the association between country-level wealth and pain depends on the moderating influence of country-level income inequality, measured by the Gini index. The lower the income inequality, the more likely it is that poor countries experience the highest and rich countries the lowest prevalence of pain. In contrast, the higher the income inequality, the more nonlinear the association between country-level wealth and pain reporting such that the highest prevalence is seen in highly nonegalitarian middle-income countries. Our findings help to characterize the global distribution of pain and pain inequalities, and to identify national-level factors that shape pain inequalities.
Collapse
Affiliation(s)
- Zachary Zimmer
- Department of Family Studies and Gerontology, Global Aging and Community Initiative, 166 Bedford Highway, McCain Centre 201C, Halifax, Nova Scotia B2M2J6, Canada
| | - Anna Zajacova
- Department of Sociology, Social Science Centre Room 5306, University of Western Ontario, London, Ontario N6A5C2, Canada
| | - Kathryn Fraser
- Global Aging and Community Initiative, 166 Bedford Highway, McCain Centre 201C, Halifax, Nova Scotia B2M2J6, Canada
| | - Daniel Powers
- Department of Sociology, RLP 2.622J, University of Texas at Austin, Austin, TX 78712-1086, USA
| | - Hanna Grol-Prokopczyk
- Department of Sociology, 430 Park Hall, University at Buffalo, Buffalo, NY 14260-4140, USA
| |
Collapse
|
4
|
Ayala-Beas SR, Rodriguez Minaya YE. [Health expenditure and health outcomes in Latin America and the CaribbeanGastos em saúde e resultados de saúde na América Latina e no Caribe]. Rev Panam Salud Publica 2023; 47:e136. [PMID: 37829578 PMCID: PMC10566531 DOI: 10.26633/rpsp.2023.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2023] [Accepted: 07/12/2023] [Indexed: 10/14/2023] Open
Abstract
Objective To determine the effect of public and private health expenditure on health outcomes in Latin American and Caribbean countries from 2000 to 2019. Methods A health production function was used, wherein life expectancy at birth and infant mortality rate were considered as indicators of health outcomes. Panel data econometrics were applied, using data from a 33-country sample for the period from 2000 to 2019. Results According to estimates, a 1% increase in public health expenditure is associated with a 0.019% increase in life expectancy, and a 1% increase in private health expenditure increases life expectancy by 0.023%. At the same time, a 1% increase in public health expenditure reduces the infant mortality rate by -0.168%, whereas the effect of private health expenditure on infant mortality is not statistically significant. Conclusions The results provide evidence of the effect of public health expenditure in reducing infant mortality and increasing life expectancy, while private health expenditure has a positive effect only on the latter metric. The findings have important political implications for the countries of the Region in the post-pandemic context of limited fiscal space.
Collapse
Affiliation(s)
- Sebastian Rolando Ayala-Beas
- Universidad Nacional Santiago Antúnez de MayoloHuarazPerúUniversidad Nacional Santiago Antúnez de Mayolo, Huaraz, Perú.
| | - Yony Edwin Rodriguez Minaya
- Universidad Nacional Santiago Antúnez de MayoloHuarazPerúUniversidad Nacional Santiago Antúnez de Mayolo, Huaraz, Perú.
| |
Collapse
|
5
|
Lee J, Jukarainen S, Karvanen A, Dixon P, Davies NM, Smith GD, Natarajan P, Ganna A. Quantifying the causal impact of biological risk factors on healthcare costs. Nat Commun 2023; 14:5672. [PMID: 37704630 PMCID: PMC10499912 DOI: 10.1038/s41467-023-41394-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Accepted: 08/29/2023] [Indexed: 09/15/2023] Open
Abstract
Understanding the causal impact that clinical risk factors have on healthcare-related costs is critical to evaluate healthcare interventions. Here, we used a genetically-informed design, Mendelian Randomization (MR), to infer the causal impact of 15 risk factors on annual total healthcare costs. We calculated healthcare costs for 373,160 participants from the FinnGen Study and replicated our results in 323,774 individuals from the United Kingdom and Netherlands. Robust causal effects were observed for waist circumference (WC), adult body mass index, and systolic blood pressure, in which a standard deviation increase corresponded to 22.78% [95% CI: 18.75-26.95], 13.64% [10.26-17.12], and 13.08% [8.84-17.48] increased healthcare costs, respectively. A lack of causal effects was observed for certain clinically relevant biomarkers, such as albumin, C-reactive protein, and vitamin D. Our results indicated that increased WC is a major contributor to annual total healthcare costs and more attention may be given to WC screening, surveillance, and mitigation.
Collapse
Affiliation(s)
- Jiwoo Lee
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
- Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA, USA
- Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
| | - Sakari Jukarainen
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
| | - Antti Karvanen
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
| | - Padraig Dixon
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
| | - Neil M Davies
- Division of Psychiatry, University College London, Maple House, 149 Tottenham Court Rd, London, W1T 7NF, UK
- Department of Statistical Sciences, University College London, London, WC1E 6BT, UK
- K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway
- Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, Bristol, UK
| | - George Davey Smith
- Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, Bristol, UK
| | - Pradeep Natarajan
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA, USA
- Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
- Department of Medicine, Harvard Medical School, Boston, MA, USA
| | - Andrea Ganna
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
| |
Collapse
|
6
|
Frankovic I, Kuhn M. Health insurance, endogenous medical progress, health expenditure growth, and welfare. JOURNAL OF HEALTH ECONOMICS 2023; 87:102717. [PMID: 36638641 DOI: 10.1016/j.jhealeco.2022.102717] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Revised: 11/23/2022] [Accepted: 12/08/2022] [Indexed: 06/17/2023]
Abstract
We study the impact of health insurance expansion on medical spending, longevity and welfare in an OLG economy in which individuals purchase health care to lower mortality and medical progress is profit-driven. Three sectors are considered: final goods production; a health care sector, selling medical services to individuals; and an R&D sector, selling increasingly effective medical technology to the health care sector. We calibrate the model to the development of the US economy/health care system from 1965 to 2005 and study numerically the impact of the insurance expansion. We find that more extensive health insurance accounts for a large share of the rise in US health spending but also boosts the rate of medical progress. A welfare analysis shows that while the subsidization of health care through health insurance creates excessive health care spending, the gains in life expectancy brought about by induced medical progress more than compensate for this.
Collapse
Affiliation(s)
| | - Michael Kuhn
- International Institute for Applied Systems Analysis (IIASA), Austria; Wittgenstein Centre (IIASA, OeAW, University of Vienna), Austria.
| |
Collapse
|
7
|
Boachie MK, Agyemang J, Immurana M. Health sector funding in Ghana: The effect of IMF conditionalities. DIALOGUES IN HEALTH 2022; 1:100045. [PMID: 38515887 PMCID: PMC10953935 DOI: 10.1016/j.dialog.2022.100045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 08/29/2022] [Accepted: 09/13/2022] [Indexed: 03/23/2024]
Abstract
Purpose This paper examines the factors influencing government health spending in Ghana with a particular focus on IMF conditionalities. Design/methodology/approach We estimate four simultaneous equations using three-stage least squares (3SLS) estimator. The data used cover the period 1980-2014. Findings After controlling for some other factors affecting government health spending, the results show that democracy and foreign aid significantly increase public sector health funding. IMF programs with its associated conditionalities insignificantly reduce public health spending Ghana. Originality/value This study provides important evidence on the impact of IMF conditionalities on health sector funding in Ghana. The results will serve as guide to policymakers when negotiating for IMF credit so that such arrangements do not obstruct health sector funding.
Collapse
Affiliation(s)
- Micheal Kofi Boachie
- SAMRC/Wits Centre for Health Economics and Decision – PRICELESS SA, School of Public Health, University of the Witwatersrand, Johannesburg 2193, South Africa
| | - John Agyemang
- School of Public Health/Internal Audit Department, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Mustapha Immurana
- Institute of Health Research, University of Health and Allied Sciences, Ho, Ghana
| |
Collapse
|
8
|
Schuettig W, Sundmacher L. The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS : HEPAC : HEALTH ECONOMICS IN PREVENTION AND CARE 2022; 23:1329-1340. [PMID: 35091856 PMCID: PMC9550748 DOI: 10.1007/s10198-022-01428-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Accepted: 01/06/2022] [Indexed: 06/14/2023]
Abstract
Ambulatory care sensitive hospitalizations are widely considered as important measures of access to as well as quality and performance of primary care. In our study, we investigate the impact of spending, process quality and continuity of care in the ambulatory care sector on ambulatory care sensitive hospitalizations in patients with type 2 diabetes. We used observational data from Germany's major association of insurance companies from 2012 to 2014 with 55,924 patients, as well as data from additional sources. We conducted negative binomial regression analyses with random effects at the district level. To control for potential endogeneity of spending and physician density in the ambulatory care sector, we used an instrumental variable approach. We controlled for a wide range of covariates, such as age, sex, and comorbidities. The results of our analysis suggest that spending in the ambulatory care sector has weak negative effects on ambulatory care sensitive hospitalizations. We also found that continuity of care was negatively associated with hospital admissions. Patients with type 2 diabetes are at increased risk of hospitalization resulting from ambulatory care sensitive conditions. Our study provides some evidence that increased spending and improved continuity of care while controlling for process quality in the ambulatory care sector may be effective ways to reduce the rate of potentially avoidable hospitalizations among patients with type 2 diabetes.
Collapse
Affiliation(s)
- Wiebke Schuettig
- Chair of Health Economics, Technical University of Munich, Georg-Brauchle-Ring 60/62, 80992 Munich, Germany
| | - Leonie Sundmacher
- Chair of Health Economics, Technical University of Munich, Georg-Brauchle-Ring 60/62, 80992 Munich, Germany
| |
Collapse
|
9
|
Moler-Zapata S, Kreif N, Ochalek J, Mirelman AJ, Nadjib M, Suhrcke M. Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach. APPLIED HEALTH ECONOMICS AND HEALTH POLICY 2022; 20:881-891. [PMID: 35997895 DOI: 10.1007/s40258-022-00752-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 07/25/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND The marginal productivity of a country's healthcare system refers to the health gains produced per unit change in the level of spending. In budget-constrained settings, this metric reflects the opportunity cost, in terms of health gains forgone, of committing additional or existing resources to alternative uses within the healthcare system. It can therefore assist in evidence-based decisions on whether different interventions represent good value for money. OBJECTIVE The aim of this paper was to estimate the marginal productivity of the Indonesian healthcare system using subnational data, and to use this to inform health opportunity costs in the country. METHODS We define a dynamic health production function to model the stream of effects of current and prior public health spending decisions on population under-five mortality. To estimate the model, we use data from the 33 Indonesian provinces for the 2004-2012 period. The estimated elasticity is then translated into gains in terms of cost per DALY (disability-adjusted life-year) averted. We use dynamic panel data methods to address potential endogeneity issues in the model. RESULTS Our base-case estimates suggest that a 1% expansion in the level of health spending reduces under-five mortality by 0.38% (95% CI 0.00-0.76), which translates into a cost of averting one DALY of $235 (2019 US$). CONCLUSION With Indonesia aiming for universal health coverage, our results support these efforts by highlighting the associated benefits resulting from increases in public health expenditure and have the potential to inform the decision-making process about a suitable locally relevant cost-effectiveness threshold.
Collapse
Affiliation(s)
- Silvia Moler-Zapata
- Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, WC1H 9SH, UK.
| | - Noémi Kreif
- Centre for Health Economics, University of York, Heslington, York, YO10 5DD, UK
| | - Jessica Ochalek
- Centre for Health Economics, University of York, Heslington, York, YO10 5DD, UK
| | - Andrew J Mirelman
- Centre for Health Economics, University of York, Heslington, York, YO10 5DD, UK
| | - Mardiati Nadjib
- Department of Health Policy and Administration, Faculty of Public Health, University of Indonesia, Depok, Indonesia
| | - Marc Suhrcke
- Centre for Health Economics, University of York, Heslington, York, YO10 5DD, UK
- Luxembourg Institute of Socio-economic Research, 4366, Esch-sur-Alzette, Luxembourg
| |
Collapse
|
10
|
Liu H, Zhong K. Relationship between health spending, life expectancy and renewable energy in China: A new evidence from the VECM approach. Front Public Health 2022; 10:993546. [PMID: 36339134 PMCID: PMC9631790 DOI: 10.3389/fpubh.2022.993546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Accepted: 09/05/2022] [Indexed: 01/26/2023] Open
Abstract
There has been a growing trend in health spending and renewable energy consumption in China over the past few decades, which has positive implications for health outcomes, such as life expectancy. Therefore, the main objective of this study is to empirically analyze the impact of health expenditures and renewable energy on life expectancy in China. We used the time series data from 2000Q1 to 2020Q4 and applied the VECM approach for the data analysis. The results of this study suggest a long run association between health spending, life expectancy and renewable energy. The increase in health spending improves life expectancy, while renewable energy consumption also positively affects life expectancy in China. Therefore, the government should allocate sufficient funding to the health sector in order to attain higher life expectancy in the country. In addition, the government should also provide incentives for the consumption and production of renewable energy, which could help to achieve the sustainable development goal and life expectancy.
Collapse
Affiliation(s)
- Hui Liu
- School of Finance and Taxation, Shandong University of Finance and Economics, Jinan, China,*Correspondence: Hui Liu
| | - Kaiyang Zhong
- School of Economics and Management, Binzhou University, Binzhou, China,School of Economic Information Engineering, Southwestern University of Finance and Economics, Chengdu, China,Kaiyang Zhong
| |
Collapse
|
11
|
Sampson C, Zamora B, Watson S, Cairns J, Chalkidou K, Cubi-Molla P, Devlin N, García-Lorenzo B, Hughes DA, Leech AA, Towse A. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy. APPLIED HEALTH ECONOMICS AND HEALTH POLICY 2022; 20:651-667. [PMID: 35668345 PMCID: PMC9385803 DOI: 10.1007/s40258-022-00730-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/29/2022] [Indexed: 05/04/2023]
Abstract
There is growing interest in cost-effectiveness thresholds as a tool to inform resource allocation decisions in health care. Studies from several countries have sought to estimate health system opportunity costs, which supply-side cost-effectiveness thresholds are intended to represent. In this paper, we consider the role of empirical estimates of supply-side thresholds in policy-making. Recent studies estimate the cost per unit of health based on average displacement or outcome elasticity. We distinguish the types of point estimates reported in empirical work, including marginal productivity, average displacement, and outcome elasticity. Using this classification, we summarise the limitations of current approaches to threshold estimation in terms of theory, methods, and data. We highlight the questions that arise from alternative interpretations of thresholds and provide recommendations to policymakers seeking to use a supply-side threshold where the evidence base is emerging or incomplete. We recommend that: (1) policymakers must clearly define the scope of the application of a threshold, and the theoretical basis for empirical estimates should be consistent with that scope; (2) a process for the assessment of new evidence and for determining changes in the threshold to be applied in policy-making should be created; (3) decision-making processes should retain flexibility in the application of a threshold; and (4) policymakers should provide support for decision-makers relating to the use of thresholds and the implementation of decisions stemming from their application.
Collapse
Affiliation(s)
| | | | - Sam Watson
- University of Birmingham, Birmingham, UK
| | - John Cairns
- London School of Hygiene and Tropical Medicine, London, UK
| | | | | | | | - Borja García-Lorenzo
- Kronikgune Institute for Health Services Research, Basque Country, Spain
- Assessment of Innovations and New Technologies Unit, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain
| | - Dyfrig A Hughes
- Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK
| | | | | |
Collapse
|
12
|
Feldens TK, Souza KBD. Health expenditures and causa mortis: an investigation on municipalities of the State of Paraná, Brazil. CAD SAUDE PUBLICA 2022; 38:e00272421. [PMID: 35894364 DOI: 10.1590/0102-311xen272421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 05/16/2022] [Indexed: 11/21/2022] Open
Abstract
The Brazilian government shares the responsibility of financing public health among federal, state, and municipal levels. Health expenditures are thus uneven across the country and cannot contribute equally to health outcomes across disease categories. This study aims to identify how the health expenditures of municipalities affect the mortality rate in the state of Paraná by causa mortis. We considered years of life lost for each municipality, the chapters of the International Classification of Diseases (10th revision), and the elasticity of this measure in relation to public health expenditure. Considering the possibility of endogeneity, this study follows the instrumental variable approach in a panel of generalized method of moments - instrumental variable (GMM-IV) with fixed effects. Our results show that a 1% increase in health expenditure could decrease the average number of years lost specifically for some causes from 0.176% to 1.56% at the municipal level. These findings could elucidate policy perspective within state finance.
Collapse
Affiliation(s)
- Tallys Kalynka Feldens
- Universidade Federal do Paraná, Curitiba, Brasil.,Secretaria de Saúde do Estado do Paraná, Curitiba, Brasil
| | | |
Collapse
|
13
|
Aydan S, Bayin Donar G, Arikan C. Impacts of Economic Freedom, Health, and Social Expenditures on Well-Being Measured by the Better Life Index in OECD Countries. SOCIAL WORK IN PUBLIC HEALTH 2022; 37:435-447. [PMID: 34964427 DOI: 10.1080/19371918.2021.2018083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
The Organization for Economic Co-operation and Development (OECD) has developed the Better Life Index (BLI), which is a multidimensional approach to well-being. This study aims to investigate the impact of health and social expenditures as well as the economic freedom index on well-being measured by BLI among 34 OECD countries for 2013-2017 period. We estimated panel models to observe the social and health expenditure effects according to their sources and the overall impact of economic changes among countries. We find that public and private social expenditures have a positive and statistically significant impact on BLI at 1% significance level. Additionally, whereas public health expenditure has a positive and statistically significant impact on BLI at 1% significance level, the effects of private health expenditure are statistically significant at 10% significance level. The economic freedom index has a positive and statistically significant impact on BLI in both models. Both social and health expenditures should take a prominent position in policy debates for a better life.
Collapse
Affiliation(s)
- Seda Aydan
- Faculty of Economics and Administrative Sciences, Department of Health Care Management, Hacettepe University, Ankara, Turkey
| | - Gamze Bayin Donar
- Faculty of Economics and Administrative Sciences, Department of Health Care Management, Hacettepe University, Ankara, Turkey
| | - Cengiz Arikan
- Department of Risk Analysis, Tr Ministry of Trade, Ankara, Turkey
| |
Collapse
|
14
|
Xu W, Lin J. Fiscal Decentralization, Public Health Expenditure and Public Health-Evidence From China. Front Public Health 2022; 10:773728. [PMID: 35664120 PMCID: PMC9157548 DOI: 10.3389/fpubh.2022.773728] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2021] [Accepted: 04/25/2022] [Indexed: 11/13/2022] Open
Abstract
Since the beginning of the COVID-19 outbreak and the launch of the "Healthy China 2030" strategy in 2019, public health has become a relevant topic of discussion both within and outside China. The provision of public health services, which is determined by public health expenditure, is critical to the regional public health sector. Fiscal decentralization provides local governments with more financial freedom, which may result in changes to public health spending; thus, fiscal decentralization may influence public health at the regional level. In order to study the effects of fiscal decentralization on local public health expenditure and local public health levels, we applied a two-way fixed effect model as well as threshold regression and intermediate effect models to 2008-2019 panel data from China's 30 mainland provinces as well as from four municipalities and autonomous regions to study the effects of fiscal decentralization on public health. The study found that fiscal decentralization has a positive effect on increasing public health expenditure. Moreover, fiscal decentralization can promote improvements in regional public health by increasing public health expenditure and by improving the availability of regional medical public service resources. In addition, fiscal decentralization has a non-linear effect on public health.
Collapse
Affiliation(s)
- Wangzi Xu
- School of Public Health, Xiamen University, Xiamen, China
| | - Jia Lin
- International School, Jinan University, Guangzhou, China
| |
Collapse
|
15
|
Ridhwan MM, Nijkamp P, Ismail A, M.Irsyad L. The effect of health on economic growth: a meta-regression analysis. EMPIRICAL ECONOMICS 2022; 63:3211-3251. [PMID: 35431414 PMCID: PMC8995891 DOI: 10.1007/s00181-022-02226-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/10/2021] [Accepted: 02/22/2022] [Indexed: 06/14/2023]
Abstract
The main objective of this study is to examine the effect of health on economic growth based on 719 estimates obtained from 64 studies from all over the world. We find evidence of a publication bias towards a positive estimated effect of health on economic growth. After accounting for heterogeneity of the estimates, we show that health has a genuine positive effect on economic growth. Less developed countries seem to enjoy a higher effect of health on growth driven by the ongoing economic-demographic transition in those countries. The variation of the health effect on economic growth is also influenced by the available data, estimation procedure, model specification, publication channel, and country characteristics in each study. Studies that do not account for endogeneity seem to create an upward bias. Studies with more comprehensive variables seem to increase the estimated effect of health on growth. A higher number of years of compulsory education, longer working experience, and more favourable environmental conditions also increase the effect size. Overall, our results confirm the key role of the health factor in explaining economic growth across countries.
Collapse
Affiliation(s)
| | - Peter Nijkamp
- Open University, Heerlen, The Netherlands
- A.I, Cuza University, Iasi, Romania
| | - Affandi Ismail
- Bank Indonesia Institute, Bank Indonesia, Jakarta, Indonesia
| | - Luthfi M.Irsyad
- Bank Indonesia Institute, Bank Indonesia, Jakarta, Indonesia
| |
Collapse
|
16
|
Testa A, Weiss DB, Santos MR. Opioid mortality, public health care expenditures, and cross-national homicide rates: findings from 25 OECD countries, 2000-2017. Soc Psychiatry Psychiatr Epidemiol 2022; 57:673-682. [PMID: 34591120 DOI: 10.1007/s00127-021-02177-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Accepted: 09/22/2021] [Indexed: 10/20/2022]
Abstract
PURPOSE This study assesses the relationship between opioid mortality and homicide rates across 25 member countries of the organization for economic co-operation and development (OECD) over time and investigates the role of country-level public health expenditures in this relationship. METHODS Fixed effects linear regression is used to assess the longitudinal association between opioid mortality and cross-national homicide rates in 25 OECD countries between 2000 and 2017. Moderation analyses are conducted to assess the interaction between opioid mortality rates and public health expenditures per capita. RESULTS Study findings revealed a positive bivariate association between opioid mortality and homicide rates. However, this association became null after controlling for public health expenditures. Moderation analyses revealed that there is a strong positive association between opioid mortality and homicide rates when public health expenditures are low, which becomes gradually weaker at higher levels of health expenditures. CONCLUSION This study suggests one consequence of the opioid epidemic may be increased homicide rates, and this association is stronger in countries with lower public health expenditures. These findings highlight the potential role of governments to combat the associated harms of rising opioid use through greater investments in public health care.
Collapse
Affiliation(s)
- Alexander Testa
- Department of Criminology and Criminal Justice, University of Texas at San Antonio, 501 W. César E. Chávez Blvd, San Antonio, TX, 78207, USA.
| | - Douglas B Weiss
- School of Criminology and Criminal Justice, California State University, San Bernardino, CA, USA
| | - Mateus R Santos
- Department of Criminology, University of South Florida, Tampa, FL, USA
| |
Collapse
|
17
|
Tanaka T, Okamoto S, Canning D. National Health Spending, Health-Care Resources, Service Utilization, and Health Outcomes. Am J Epidemiol 2022; 191:386-396. [PMID: 34128527 DOI: 10.1093/aje/kwab179] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 06/04/2021] [Accepted: 06/11/2021] [Indexed: 11/12/2022] Open
Abstract
Cross-national studies of the linkage of health-care spending with population health have found surprisingly limited evidence of benefits. In this study, we investigated associations between national health spending and key health resources (numbers of hospital beds, physicians, and nurses) and utilization of cost-effective health services (antenatal care, attendance of trained staff at childbirth, and measles vaccination), sometimes in ways that curtail the benefits of that expenditure. Using annual panel data from 1990-2014 covering 140 countries, we show that variation in health spending as a share of gross domestic product is not associated with decreased mortality rates. It is also very weakly associated with increased health-care resources and health service utilization (elasticity smaller than 0.08), with the association being close to 0 in low-income countries. In addition, countries with a higher share of out-of-pocket spending have a significantly lower level of health resources and service utilization. These findings, rather than the ineffectiveness of health care, could explain the lack of impact of health spending. In contrast, gross domestic product per capita is significantly associated with increased health resources, a higher rate of service utilization, and lower mortality rates, suggesting that income is an important determinant of public health.
Collapse
|
18
|
Fritz M, Fromell H. How to dampen the surge of non-communicable diseases in Southeast Asia: insights from a systematic review and meta-analysis. Health Policy Plan 2022; 37:152-167. [PMID: 34791261 PMCID: PMC8757494 DOI: 10.1093/heapol/czab138] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Revised: 10/07/2021] [Accepted: 11/12/2021] [Indexed: 01/04/2023] Open
Abstract
Non-communicable diseases (NCDs), such as diabetes, cancer, cardiovascular diseases and chronic respiratory diseases, have overtaken infectious diseases as the number one cause of death worldwide. The rise of these diseases is especially grave in Southeast Asia, where existing research however falls short on offering guidance on how policy can best prevent and control NCDs in the region. Additionally, low- and middle-income countries in Southeast Asia cannot directly incorporate lessons drawn from interventions in richer countries, since health system capacities and human and financial resources are thoroughly different. Preventive interventions, thus, need to correspond to local capacities and require contextual solutions. In this article, we provide a systematic review of a wide scope of NCD interventions conducted in Southeast Asia to inform about existing intervention designs and to derive sound evidence of their effectiveness. Our literature search results in 51 studies from five Southeast Asian countries from which we can extract 204 estimates. We sort the studies into six intervention categories and analyse them with respect to 23 different health and behavioural outcomes. While we find positive and significant average effects across all six types of interventions, we also document evidence of substantial publication bias. Using a meta-regression approach in which we correct for the publication bias, we instead fail to confirm positive average effects for some interventions. Especially dietary and physical activity interventions fail to achieve improvements in analysed health outcomes, while programs focusing on smoking cessation, on the take-up of preventive screening activities or educating patients on how to cope with NCDs achieve sizeable effects. We also present evidence that the size of the effect differs with the participants' characteristics as well as with design features of the intervention. For local policymakers, the results provide important knowledge on how to address the increasing NCD burden in the coming years.
Collapse
Affiliation(s)
- Manuela Fritz
- Faculty of Economics, Business and Information Systems, Chair of Development Economics, University of Passau, Innstraße 29, Passau 94032, Germany
- Department of Economics, Econometrics and Finance, University of Groningen, Nettelbosje 2, Groningen 9747 AE, The Netherlands
| | - Hanna Fromell
- Department of Economics, Econometrics and Finance, University of Groningen, Nettelbosje 2, Groningen 9747 AE, The Netherlands
- Department of Economics and Business Economics, Aarhus University, Fuglesangs Allé 4, Aarhus V 8210, Denmark
| |
Collapse
|
19
|
Shao Y, Goštautaitė B, Wang M, Ng TWH. Age and sickness absence: Testing physical health issues and work engagement as countervailing mechanisms in a cross‐national context. PERSONNEL PSYCHOLOGY 2021. [DOI: 10.1111/peps.12498] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Chen S, Kuhn M, Prettner K, Bloom DE, Wang C. Macro-level efficiency of health expenditure: Estimates for 15 major economies. Soc Sci Med 2021; 287:114270. [PMID: 34482274 PMCID: PMC8412416 DOI: 10.1016/j.socscimed.2021.114270] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2021] [Revised: 07/05/2021] [Accepted: 07/23/2021] [Indexed: 12/19/2022]
Abstract
The coronavirus disease 2019 (COVID-19) pandemic highlights the importance of strong and resilient health systems. Yet how much a society should spend on healthcare is difficult to determine because additional health expenditures imply lower expenditures on other types of consumption. Furthermore, the welfare-maximizing ("efficient") aggregate amount and composition of health expenditures depend on efficiency concepts at three levels that often get blurred in the debate. While the understanding of efficiency is good at the micro- and meso-levels-that is, relating to minimal spending for a given bundle of treatments and to the optimal mix of different treatments, respectively-this understanding rarely links to the efficiency of aggregate health expenditure at the macroeconomic level. While micro- and meso-efficiency are necessary for macro-efficiency, they are not sufficient. We propose a novel framework of a macro-efficiency score to assess welfare-maximizing aggregate health expenditure. This allows us to assess the extent to which selected major economies underspend or overspend on health relative to their gross domestic products per capita. We find that all economies under consideration underspend on healthcare with the exception of the United States. Underspending is particularly severe in China, India, and the Russian Federation. Our study emphasizes that the major and urgent issue in many countries is underspending on health at the macroeconomic level, rather than containing costs at the microeconomic level.
Collapse
Affiliation(s)
- Simiao Chen
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany
| | - Michael Kuhn
- International Institute for Applied Systems Analysis (IIASA), Laxenburg, Austria; Wittgenstein Centre (IIASA, OeAW, University of Vienna), Vienna Institute of Demography, Vienna, Austria
| | - Klaus Prettner
- Wittgenstein Centre (IIASA, OeAW, University of Vienna), Vienna Institute of Demography, Vienna, Austria; Vienna University of Economics and Business (WU), Department of Economics, Vienna, Austria
| | - David E Bloom
- Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Chen Wang
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China; Chinese Academy of Engineering, Beijing, China.
| |
Collapse
|
21
|
Castro M, Mattos E, Patriota F. The effects of health spending on the propagation of infectious diseases. HEALTH ECONOMICS 2021; 30:2323-2344. [PMID: 34247434 DOI: 10.1002/hec.4388] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2020] [Revised: 06/22/2021] [Accepted: 06/24/2021] [Indexed: 06/13/2023]
Abstract
We explore the discontinuity in the allocation of the main federal grant to Brazilian municipalities to identify the local effects of health spending and the spillovers into the bordering jurisdictions. Fiscal reactions are asymmetric: small neighbors reduce health spending, while we do not find a significant budgetary response in the largest neighbor. Our results suggest a reduction in the spread of infectious diseases in the neighbors, with fewer residents hospitalized with gastrointestinal infections. In addition, the elderly demand less hospitalization in the largest bordering jurisdictions due to respiratory infectious diseases. Finally, we find a direct and significant reduction in infant mortality, consistent with the observed pediatricians' increase, while the spillover effects on neighbors' mortality rates are not conclusive.
Collapse
Affiliation(s)
- Marcelo Castro
- Federal University of Uberlândia (UFU), Campus UFU Santa Mônica, Uberlândia, Minas Gerais, Brazil
| | - Enlinson Mattos
- São Paulo School of Economics, Fundação Getúlio Vargas, São Paulo, São Paulo, Brazil
| | | |
Collapse
|
22
|
Hu F, Shi X, Wang H, Nan N, Wang K, Wei S, Li Z, Jiang S, Hu H, Zhao S. Is Health Contagious?-Based on Empirical Evidence From China Family Panel Studies' Data. Front Public Health 2021; 9:691746. [PMID: 34277551 PMCID: PMC8283520 DOI: 10.3389/fpubh.2021.691746] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Accepted: 06/07/2021] [Indexed: 11/13/2022] Open
Abstract
This study empirically analysed the contagion of health using data from China Family Panel Studies. We first controlled variables related to health behaviour, medical conditions, individual characteristics, household characteristics, group characteristics, and prefecture/county characteristics and then employed multiple methods for estimation. The estimates showed that the average health level of others in the community had a significant positive effect on individual self-rated health-health was contagious. The measurement results remained robust after the endogeneity of the core explanatory variables was controlled using two-stage least squares. Furthermore, by analysing the heterogeneity of health contagion, we found that the contagion effect of health varied with the level of medical care, household affiliation, gender, rural/urban areas, and age groups. The contagion effect of health was more pronounced in the elderly population and the rural areas of the central region, where the level of medical care is relatively low, whereas it did not differ significantly between genders. Finally, the learning or imitation mechanism and social interaction mechanism of health contagion were examined.
Collapse
Affiliation(s)
- Feng Hu
- Global Value Chain Research Center, Zhejiang Gongshang University, Hangzhou, China
| | - Xiaojiao Shi
- Global Value Chain Research Center, Zhejiang Gongshang University, Hangzhou, China
| | - Haiyan Wang
- School of Economics, East China Normal University, Shanghai, China
| | - Nan Nan
- School of Economics and Management, Shihezi University, Shihezi, China
| | - Kui Wang
- School of Economics, Huazhong University of Science and Technology, Wuhan, China
| | - Shaobin Wei
- International Business Research Institute, Zhejiang Gongshang University, Hangzhou, China
| | - Zhao Li
- School of Master of Business Administration, Zhejiang Gongshang University, Hangzhou, China
| | - Shanshan Jiang
- International Business Research Institute, Zhejiang Gongshang University, Hangzhou, China
| | - Hao Hu
- School of Economics, Shanghai University, Shanghai, China
| | - Shuang Zhao
- International Business Research Institute, Zhejiang Gongshang University, Hangzhou, China
| |
Collapse
|
23
|
Breyer F, Lorenz N. The "red herring" after 20 years: ageing and health care expenditures. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS : HEPAC : HEALTH ECONOMICS IN PREVENTION AND CARE 2021; 22:661-667. [PMID: 32500244 PMCID: PMC8214577 DOI: 10.1007/s10198-020-01203-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Affiliation(s)
- Friedrich Breyer
- Department of Economics, University of Konstanz, P.O. Box 135, 78457 Konstanz, Germany
| | - Normann Lorenz
- University of Trier, Universitätsring 15, 54296 Trier, Germany
| |
Collapse
|
24
|
Balkhi B, Alshayban D, Alotaibi NM. Impact of Healthcare Expenditures on Healthcare Outcomes in the Middle East and North Africa (MENA) Region: A Cross-Country Comparison, 1995-2015. Front Public Health 2021; 8:624962. [PMID: 33614570 PMCID: PMC7890180 DOI: 10.3389/fpubh.2020.624962] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Accepted: 12/31/2020] [Indexed: 12/19/2022] Open
Abstract
The association between healthcare expenditures and outcomes, mainly mortality and life expectancy, is complex. The real explanation for this association is not clear, especially in the Middle East and North Africa (MENA) region. This study assesses the impact of health expenditures on improving healthcare systems and health status and finds a relationship between health expenditures and health outcomes across different region. Annual time series data on healthcare spending and outcomes from 1995 to 2015 were used for MENA region in comparison to developed and developing countries. Health expenditure was adjusted by the consumer price index equation to the 2015 US dollar eliminate the impact of inflation on our results. For many countries, spending on healthcare continues to rise, Among MENA countries, we found that the United Arab Emirates and Kuwait spent more per capita on health, $1,711 and $1,420, respectively, than any other countries in the region. Although this study demonstrated a relationship between total healthcare expenditure and outcomes, some countries spend more on healthcare but have shorter life expectancy. In most countries, efficient and effective utilization of healthcare resources is the key strategy for improving health outcomes in any country. The lack of a positive correlation between healthcare spending and life expectancy may indicate that health resources are not allocated effectively. In those cases, increasing health spending does not guarantee that there is any kind of improvement in healthcare.
Collapse
Affiliation(s)
- Bander Balkhi
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
| | - Dhfer Alshayban
- Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Nawaf M Alotaibi
- Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia
| |
Collapse
|
25
|
Nguimkeu P, Tadadjeu S. Why is the number of COVID-19 cases lower than expected in Sub-Saharan Africa? A cross-sectional analysis of the role of demographic and geographic factors. WORLD DEVELOPMENT 2021; 138:105251. [PMID: 33106726 PMCID: PMC7577660 DOI: 10.1016/j.worlddev.2020.105251] [Citation(s) in RCA: 42] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Unlike initially predicted by WHO, the severity of the novel coronavirus pandemic has remained relatively low in Sub-Saharan Africa, more than two months after the first confirmed cases were identified. In this paper, we analyze the extent to which demographic and geographic factors associated to the disease explain this phenomenon. We use publicly available data from a cross-section of 182 countries worldwide, and we employ a regression analysis that accounts for possible misreporting of COVID-19 cases, as well as a Ramsey-type specification that preserves degree of freedom. We found that proportion of population aged 65+, population density, and urbanization are significantly positively associated with high numbers of active infected cases, while mean temperature around the first quarter (January-March) is negatively associated to this COVID-19 outcome. These factors are those for which Africa has a comparative advantage. In contrast, factors for which Africa has a relative disadvantage, such as income and quality of health care infrastructure, are found to be insignificant predictors of the spread of the pandemic. These results hold even when accounting for possible underreporting, as well as differences in the duration of the epidemic in each country, as measured by the time elapsed since the first confirmed case occurred. We conclude that differences in demographic and geographic characteristics help understand the relatively low progression of the pandemic in sub-Saharan Africa as well as the gap in the number of active cases between this region and the rest of the World. We also found, however, that this gap is insignificant beyond these factors, and is expected to narrow over time as the pandemic evolves. These results provide insights for relevant urban policies and kinds of development planning to consider in the fight against disease spreads of the coronavirus type.
Collapse
Affiliation(s)
- Pierre Nguimkeu
- Department of Economics, Andrew Young School of Policy Studies, Georgia State University, 55 Park Place, Atlanta, GA 30303, USA
| | - Sosson Tadadjeu
- Faculty of Economics and Management, University of Dschang, P.O. Box 96, Dschang, Cameroon
| |
Collapse
|
26
|
Edoka IP, Stacey NK. Estimating a cost-effectiveness threshold for health care decision-making in South Africa. Health Policy Plan 2020; 35:546-555. [PMID: 32125375 PMCID: PMC7225568 DOI: 10.1093/heapol/czz152] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/05/2019] [Indexed: 11/14/2022] Open
Abstract
Cost-effectiveness thresholds are important decision rules that determine whether health interventions represent good value for money. In low- and middle-income countries, the World Health Organization (WHO) one to three times per capita gross domestic product (GDP) per disability-adjusted life years (DALYs) averted has been the most widely used threshold for informing resource allocation decisions. However, in 2016, the WHO withdrew recommendations for using this threshold, creating a significant vacuum in South Africa and many countries that rely on results of cost-effectiveness analyses for making resource allocation decisions. This study estimates a cost-effectiveness threshold that reflects the health opportunity cost of health spending in South Africa using a three-step approach. First, marginal returns to health spending was estimated as health spending elasticity for crude death rates using a fixed effect estimation approach. Second, the opportunity cost of health spending was estimated as DALYs averted. Finally, a cost per DALY averted threshold was estimated as the inverse of the marginal product of health spending. We show that 1% of total health spending in 2015 (equivalent to approximately ZAR 1.54 billion/USD 120.7 million) averted 1050 deaths, 34 180 years of life lost, 5880 years lived with disability and 40 055 DALYs. The cost-effectiveness threshold was estimated at approximately ZAR 38 500 (USD 3015) per DALY averted, ∼53% of South Africa's per capita GDP in 2015 (ZAR 72 700/USD 5700) and lower than the previously recommended one to three times per capita GDP. As South Africa moves towards implementing universal health coverage reforms through National Health Insurance by 2025, the adoption of a threshold that reflects health opportunity costs will be crucial for ensuring efficiency in the allocation of scarce resources. This study provides useful insight into the magnitude of the health opportunity cost of health spending in South Africa and highlights the need for further research.
Collapse
Affiliation(s)
- Ijeoma P Edoka
- SAMRC Centre for Health Economics and Decision Science-PRICELESS SA, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, South Africa
| | - Nicholas K Stacey
- SAMRC Centre for Health Economics and Decision Science-PRICELESS SA, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, South Africa
| |
Collapse
|
27
|
Arcà E, Principe F, Van Doorslaer E. Death by austerity? The impact of cost containment on avoidable mortality in Italy. HEALTH ECONOMICS 2020; 29:1500-1516. [PMID: 32805073 PMCID: PMC7754121 DOI: 10.1002/hec.4147] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Revised: 07/09/2020] [Accepted: 07/24/2020] [Indexed: 05/23/2023]
Abstract
Does austerity in health care affect health and healthcare outcomes? We examine the intended and unintended effects of the Italian austerity policy Piano di Rientro aimed at containing the cost of the healthcare sector. Using an instrumental variable strategy that exploits the temporal and geographical variation induced by the policy rollout, we find that the policy was successful in alleviating deficits by reducing expenditure, mainly in the southern regions, but also resulted in a 3% rise in avoidable deaths among both men and women, a reduction in hospital capacity and a rise in south-to-north patient migration. These findings suggest that-even in a high-income country with relatively low avoidable mortality like Italy-spending cuts can hurt survival.
Collapse
Affiliation(s)
- Emanuele Arcà
- Erasmus School of Health Policy & ManagementErasmus University RotterdamRotterdamThe Netherlands
| | - Francesco Principe
- Erasmus School of EconomicsErasmus University RotterdamRotterdamThe Netherlands
| | - Eddy Van Doorslaer
- Erasmus School of Health Policy & ManagementErasmus University RotterdamRotterdamThe Netherlands
- Erasmus School of EconomicsErasmus University RotterdamRotterdamThe Netherlands
| |
Collapse
|
28
|
Ochalek J, Wang H, Gu Y, Lomas J, Cutler H, Jin C. Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach. PHARMACOECONOMICS 2020; 38:1319-1331. [PMID: 32856280 DOI: 10.1007/s40273-020-00954-y] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
BACKGROUND Health technology assessment has been increasingly used in China, having been legally mandated in 2019, to inform reimbursement decisions and price negotiations between the National Healthcare Security Administration and pharmaceutical companies around the price of new pharmaceuticals. The criteria currently used to judge cost effectiveness and inform pricing negotiations, 3 × GDP per capita, is based on the rule of thumb previously recommended by the World Health Organization rather than an estimate based on an empirical assessment of health opportunity costs. OBJECTIVE The objective of this study was to inform a cost-effectiveness threshold for health technology assessment in China that accounts for health opportunity cost. METHODS The elasticity of health outcomes with respect to health expenditure was estimated using variations across 30 provincial-level administrative divisions in 2017 controlling for a range of other factors and using an instrumental variable approach to account for endogeneity to assess robustness of results. The estimated elasticity was then used to calculate the cost per disability-adjusted life-year (DALY) averted by variations in Chinese health expenditure at the margin. RESULTS The range estimated from this study, 27,923-52,247 (2017 RMB) (central estimate 37,446) per DALY averted or 47-88% of GDP per capita (central estimate 63%), shows that a cost per DALY averted cost-effectiveness threshold that reflects health opportunity costs is below 1 × GDP per capita. CONCLUSION Our results suggest that the current cost-effectiveness threshold used in China is too high; continuing to use it risks decisions that reduce overall population health.
Collapse
Affiliation(s)
- Jessica Ochalek
- Centre for Health Economics, University of York, Heslington, York, YO10 5DD, UK
| | - Haiyin Wang
- Shanghai Health Development Research Centre, Shanghai, 201199, China
| | - Yuanyuan Gu
- Centre for the Health Economy, Macquarie University, Sydney, NSW, 2109, Australia.
| | - James Lomas
- Centre for Health Economics, University of York, Heslington, York, YO10 5DD, UK
| | - Henry Cutler
- Centre for the Health Economy, Macquarie University, Sydney, NSW, 2109, Australia
| | - Chunlin Jin
- Shanghai Health Development Research Centre, Shanghai, 201199, China
| |
Collapse
|
29
|
Lopreite M, Zhu Z. The effects of ageing population on health expenditure and economic growth in China: A Bayesian-VAR approach. Soc Sci Med 2020; 265:113513. [PMID: 33199036 DOI: 10.1016/j.socscimed.2020.113513] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 10/18/2020] [Accepted: 11/07/2020] [Indexed: 11/29/2022]
Abstract
The increasing proportion of the population aged 65 or over has generated a global rise of health spending due to higher demand for medical and long-term care services, which has become a growing challenge to the sustainability of public finances across countries. This phenomenon is especially prominent in China, which has experienced accelerated rates of both economic growth and population ageing over the past four decades. Using Bayesian-VAR (B-VAR) models we compute the impulse response functions (IRFs) and the forecast error variance decomposition functions (FEVDs) to empirically examine the dynamic relationships between ageing index, life expectancy, economic growth and health expenditure in China. We compare China with the USA which has distinct trajectories of population structure and economic development to better understand the former's dynamic patterns. We find a pronounced response for both the USA and China of ageing index to life expectancy and of health spending per capita to GDP per capita, while ageing population induces a relatively strong reaction from health expenditure per capita in China. Our results are robust with either nominal or real variables. These findings suggest that, in China, a well-rounded policy accommodating economic, social and health factors is needed to improve the quality of life of the ageing population for a sustainable development of the economy.
Collapse
Affiliation(s)
- Milena Lopreite
- Scuola Superiore Sant'Anna di Pisa, Institute of Economics, Piazza dei Martiri della Libertà, 3, 56127, Pisa, Italy.
| | - Zhen Zhu
- University of Greenwich, Park Row, SE10 9LS, London, UK.
| |
Collapse
|
30
|
Goli S, Moradhvaj, James KS, Singh D, Srinivasan V. Road to family planning and RMNCHN related SDGs: Tracing the role of public health spending in India. Glob Public Health 2020; 16:546-562. [PMID: 32816632 DOI: 10.1080/17441692.2020.1809692] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Globally, public health expenditure (PHE) is closely associated with Reproductive, Maternal, Newborn, Child Health, and Nutrition (RMNCHN) and Family Planning (FP) outcomes. In India, the role of PHE in shaping the progress towards the attainment of RMNCHN and FP-related Sustainable Development Goals (SDGs) is not widely documented. Using the four consecutive rounds of National Family Health Survey (NFHS), we have investigated the progress in RMNCHN and FP indicators and their association with PHE by applying robust econometric modelling. The findings suggest that although there is noticeable progress in the RMNCHN indicators from 1992-93-2015-16, India has failed to achieve RMNCHN targets related to Millennium Development Goals (MDGs). Lack of noteworthy correlation between FP indicators and PHE supports the argument that post National Rural Health Mission (2005), the core family welfare expenditure suffered a setback despite the absolute rise in PHE. However, correlation plots and the multivariate panel data regression analyses affirm that even with a moderate rise, PHE emerges as an important predictor of RMNCHN outcomes in the country. Thus, the road to achieving RMNCHN and FP-related SDGs demands to avoid austerity on PHE and strengthen the integration of RMNCHN and FP programmes at the operational level.
Collapse
Affiliation(s)
- Srinivas Goli
- Australia India Institute (AII) NGN Research Fellow, UWA Public Policy Institute, The University of Western Australia, Perth, Australia.,Population Studies, Centre for the Study of Regional Development, Room No. 102, School of Social Sciences (SSS-3), Jawaharlal Nehru University (JNU), New Delhi, India
| | - Moradhvaj
- Population Studies, Centre for the Study of Regional Development, Jawaharlal Nehru University (JNU), New Delhi
| | - K S James
- Director & Sr. Professor, International Institute for Population Sciences (IIPS), Mumbai, India
| | - Devender Singh
- National Program Officer (Population & Development), United Nations Population Fund (UNFPA), New Delhi, India
| | - Venkatesh Srinivasan
- Assistant Representative, United Nations Population Fund (UNFPA), New Delhi, India
| |
Collapse
|
31
|
Chalkidou K, Claxton K, Silverman R, Yadav P. Value-based tiered pricing for universal health coverage: an idea worth revisiting. Gates Open Res 2020; 4:16. [PMID: 32185365 PMCID: PMC7059551 DOI: 10.12688/gatesopenres.13110.1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/07/2020] [Indexed: 10/03/2023] Open
Abstract
The pricing of medicines and health products ranks among the most hotly debated topics in health policy, generating controversy in richer and poorer markets alike. Creating the right pricing structure for pharmaceuticals and other healthcare products is particularly important for low- and middle-income countries, where pharmaceuticals account for a significant portion of total health expenditure; high medicine prices therefore threaten the feasibility and sustainability of nascent schemes for universal health coverage (UHC). We argue that a strategic system of value-based tiered pricing (VBTP), wherein each country would pay a price for each health product commensurate with the local value it provides, could improve access, enhance efficiency, and empower countries to negotiate with product manufacturers. This paper attempts to further understanding on the potential value of tiered pricing, barriers to its implementation, and potential strategies to overcome those.
Collapse
Affiliation(s)
- Kalipso Chalkidou
- Global Health Policy, Center for Global Development, London, UK
- Medicine, School of Public Health, Imperial College London, London, UK
| | - Karl Claxton
- Department of Economics, University of York, UK, York, UK
| | | | - Prashant Yadav
- Global Health Policy, Center for Global Development, London, UK
- Technology and Operations Management, INSEAD, Fontainebleau, France
| |
Collapse
|
32
|
Chalkidou K, Claxton K, Silverman R, Yadav P. Value-based tiered pricing for universal health coverage: an idea worth revisiting. Gates Open Res 2020; 4:16. [PMID: 32185365 PMCID: PMC7059551 DOI: 10.12688/gatesopenres.13110.3] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/07/2020] [Indexed: 01/29/2023] Open
Abstract
The pricing of medicines and health products ranks among the most hotly debated topics in health policy, generating controversy in richer and poorer markets alike. Creating the right pricing structure for pharmaceuticals and other healthcare products is particularly important for low- and middle-income countries, where pharmaceuticals account for a significant portion of total health expenditure; high medicine prices therefore threaten the feasibility and sustainability of nascent schemes for universal health coverage (UHC). We argue that a strategic system of value-based tiered pricing (VBTP), wherein each country would pay a price for each health product commensurate with the local value it provides, could improve access, enhance efficiency, and empower countries to negotiate with product manufacturers. This paper attempts to further understanding on the potential value of tiered pricing, barriers to its implementation, and potential strategies to overcome those.
Collapse
Affiliation(s)
- Kalipso Chalkidou
- Global Health Policy, Center for Global Development, London, UK.,Medicine, School of Public Health, Imperial College London, London, UK
| | - Karl Claxton
- Department of Economics, University of York, UK, York, UK
| | | | - Prashant Yadav
- Global Health Policy, Center for Global Development, London, UK.,Technology and Operations Management, INSEAD, Fontainebleau, France
| |
Collapse
|
33
|
Chalkidou K, Claxton K, Silverman R, Yadav P. Value-based tiered pricing for universal health coverage: an idea worth revisiting. Gates Open Res 2020; 4:16. [DOI: 10.12688/gatesopenres.13110.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/19/2020] [Indexed: 11/20/2022] Open
Abstract
The pricing of medicines and health products ranks among the most hotly debated topics in health policy, generating controversy in richer and poorer markets alike. Creating the right pricing structure for pharmaceuticals and other healthcare products is particularly important for low- and middle-income countries, where pharmaceuticals account for a significant portion of total health expenditure; high medicine prices therefore threaten the feasibility and sustainability of nascent schemes for universal health coverage (UHC). We argue that a strategic system of value-based tiered pricing (VBTP), wherein each country would pay a price for each health product commensurate with the local value it provides, could improve access, enhance efficiency, and empower countries to negotiate with product manufacturers. This paper attempts to further understanding on the potential value of tiered pricing, barriers to its implementation, and potential strategies to overcome those.
Collapse
|
34
|
Ye L, Zhang X, Geng J. Demographic transition and economic growth: Evidence from China and United States. Int J Health Plann Manage 2019; 35:e1-e11. [PMID: 31694067 DOI: 10.1002/hpm.2911] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2019] [Revised: 09/11/2019] [Accepted: 09/12/2019] [Indexed: 11/07/2022] Open
Abstract
In the context of todays ageing population, this paper uses the connectedness network model proposed by Diebold and Yilmaz in 2014 to analyse the directionality and degree of interaction between the population ageing index, life expectancy, per capita gross domestic product, and per capita health expenditure from a systematic perspective for China; then, these results from China are compared with the United States. A number of new findings can be identified, as follows: (1) for China and the United States, economic growth may promote the growth of health expenditure and increased life expectancy may cause an increase in the ageing population; (2) China's population age structure has already led to some constraints on economic growth, whereas the United StatesUS's population age structure has had a weak impact on its economic growth; and (3) the ageing population structure for China has a net impact on per capita health expenditure, whereas no such net directional impact was found in the United States. These findings support the idea that policy synergies should be strengthened in the economic, social, and health fields in order to promote both the quality of life of the ageing population and the sustainable development of the economy.
Collapse
Affiliation(s)
- Liping Ye
- College of Public Administration, Central China Normal University, Wuhan, China
| | - Xinping Zhang
- School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jiangbo Geng
- School of Finance, Zhongnan University of Economics and Law, Wuhan, China
| |
Collapse
|
35
|
Stadhouders N, Koolman X, van Dijk C, Jeurissen P, Adang E. The marginal benefits of healthcare spending in the Netherlands: Estimating cost-effectiveness thresholds using a translog production function. HEALTH ECONOMICS 2019; 28:1331-1344. [PMID: 31469510 PMCID: PMC6851736 DOI: 10.1002/hec.3946] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/23/2018] [Revised: 04/12/2019] [Accepted: 06/29/2019] [Indexed: 05/19/2023]
Abstract
New technologies may displace existing, higher-value care under a fixed budget. Countries aim to curtail adoption of low-value technologies, for example, by installing cost-effectiveness thresholds. Our objective is to estimate the opportunity cost of hospital care to identify a threshold value for the Netherlands. To this aim, we combine claims data, mortality data and quality of life questionnaires from 2012 to 2014 for 11,000 patient groups to obtain quality-adjusted life-year (QALY) outcomes and spending. Using a fixed effects translog model, we estimate that a 1% increase in hospital spending on average increases QALY outcomes by 0.2%. This implies a threshold of €73,600 per QALY, with 95% confidence intervals ranging from €53,000 to €94,000 per QALY. The results stipulate that new technologies with incremental cost effectiveness ratios exceeding the Dutch upper reference value of €80,000 may indeed displace more valuable care.
Collapse
Affiliation(s)
- Niek Stadhouders
- Scientific Institute for Quality of HealthcareRadboud University Medical CenterNijmegenNetherlands
| | - Xander Koolman
- Talma Institute, Department of Health SciencesVU University AmsterdamAmsterdamNetherlands
| | | | - Patrick Jeurissen
- Scientific Institute for Quality of HealthcareRadboud University Medical CenterNijmegenNetherlands
| | - Eddy Adang
- Radboud Institute for Health SciencesRadboud University Medical CenterNijmegenNetherlands
| |
Collapse
|
36
|
Lomas J, Martin S, Claxton K. Estimating the Marginal Productivity of the English National Health Service From 2003 to 2012. VALUE IN HEALTH : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH 2019; 22:995-1002. [PMID: 31511189 DOI: 10.1016/j.jval.2019.04.1926] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/17/2018] [Revised: 03/26/2019] [Accepted: 04/18/2019] [Indexed: 05/07/2023]
Abstract
OBJECTIVE Estimates of the marginal productivity of the health sector are required for a wide range of resource allocation decisions. Founding these estimates on robust empirical analysis can inform these decisions and improve allocative efficiency. This article estimates the annual marginal productivity of the English NHS over a 10-year period (between 2003 and 2012). METHODS Data on expenditure and mortality by program budget category are used in conjunction with socioeconomic and demographic variables from the censuses for 2001 and 2011. This article applies an econometric strategy that employs an established instrumental variable approach, which is then subjected to a number of sensitivity analyses. The results of the econometric analysis, along with additional data on the burden of disease, are used to generate an estimate of the marginal productivity for each of the study years. RESULTS We find that an additional unit of health benefit has cost between £5000 and £15 000 per quality-adjusted life-year from 2003 to 2012. Over this period these estimates (all in current prices) have increased at a faster rate than NHS price inflation, suggesting an increase in real terms. CONCLUSIONS These results are discussed in the context of the existing literature, and the potential policy implications for decisions about resource allocation are explored.
Collapse
Affiliation(s)
- James Lomas
- Centre for Health Economics, University of York, York, UK.
| | - Stephen Martin
- Department of Economics and Related Studies, University of York, York, UK
| | - Karl Claxton
- Centre for Health Economics, University of York, York, UK; Department of Economics and Related Studies, University of York, York, UK
| |
Collapse
|
37
|
Andersson MA, Wilkinson LR, Schafer MH. Does the Association Between Age and Major Illness Vary by Healthcare System Quality? Res Aging 2019; 41:988-1013. [DOI: 10.1177/0164027519864720] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
This study builds on research into global aging, by offering a multiple-indicator test of whether national healthcare system quality modifies the association between age and major illness. Recent individual-level data on morbidity among respondents aged 50 or older (16 countries; 2014 European Social Survey) are merged with nation-level healthcare indicators. Healthcare system quality is assessed using a subjective, evaluation-based approach and an objective, attributable-mortality approach. Lagged nation-level economic and health indicators are controlled to help isolate healthcare system effects. Results across subjective and objective approaches to healthcare system quality are strikingly consistent. While older individuals showed approximately a 10% reduction in probability of major illness when residing in countries with higher healthcare quality, associations between age and morbidity indices combining number and severity of illness showed greater modification by healthcare quality, with reductions around 18%. Taken together, results are suggestive of healthcare’s protective role in reducing age-related illness and disability.
Collapse
|
38
|
Kruger BP, Brown JR. Healthcare spending in the State of Louisiana. BMC Health Serv Res 2019; 19:471. [PMID: 31288800 PMCID: PMC6617944 DOI: 10.1186/s12913-019-4275-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2019] [Accepted: 06/17/2019] [Indexed: 11/29/2022] Open
Abstract
Background The State of Louisiana spends the most on Medicare beneficiaries per capita, but reports greater disparities in health status and death rates than other states. This project sought to investigate the associations between healthcare intensity, healthcare spending, and mortality in Louisiana. Methods We used a 100% sample of 2014 Medicare claims data with beneficiaries assigned to hospital referral regions in Louisiana using small area analysis. We used simple and multivariable linear regression modelling to evaluate associations between healthcare intensity, healthcare spending rates, and mortality rates. We adjusted for age, sex, race, and population health risk factors. Results We found no statistically significant associations between our measured variables when adjusted for age, sex, and race. These results were consistent after further adjusting mortality for population health risk factors. Conclusions To our knowledge, no prior studies have investigated the associations between healthcare intensity, healthcare spending, and mortality in Louisiana. Our findings suggest that increased healthcare spending in Louisiana may not improve survival. Identifying more granular aspects of healthcare contributing to spending patterns in Louisiana may provide targets for future quality improvement work.
Collapse
Affiliation(s)
- Blake P Kruger
- Jacobs School of Medicine & Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.
| | - Jeremiah R Brown
- Dartmouth College, Departments of Epidemiology, Biomedical Data Science, and The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Hanover, NH, USA
| |
Collapse
|
39
|
Siverskog J, Henriksson M. Estimating the marginal cost of a life year in Sweden's public healthcare sector. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS : HEPAC : HEALTH ECONOMICS IN PREVENTION AND CARE 2019; 20:751-762. [PMID: 30796552 PMCID: PMC6602994 DOI: 10.1007/s10198-019-01039-0] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2018] [Accepted: 02/12/2019] [Indexed: 05/19/2023]
Abstract
Although cost-effectiveness analysis has a long tradition of supporting healthcare decision-making in Sweden, there are no clear criteria for when an intervention is considered too expensive. In particular, the opportunity cost of healthcare resource use in terms of health forgone has not been investigated empirically. In this work, we therefore seek to estimate the marginal cost of a life year in Sweden's public healthcare sector using time series and panel data at the national and regional levels, respectively. We find that estimation using time series is unfeasible due to reversed causality. However, through panel instrumental variable estimation we are able to derive a marginal cost per life year of about SEK 370,000 (EUR 39,000). Although this estimate is in line with emerging evidence from other healthcare systems, it is associated with uncertainty, primarily due to the inherent difficulties of causal inference using aggregate observational data. The implications of these difficulties and related methodological issues are discussed.
Collapse
Affiliation(s)
- Jonathan Siverskog
- Centre for Medical Technology Assessment, Department of Medical and Health Sciences, Linköping University, 581 83, Linköping, Sweden.
| | - Martin Henriksson
- Centre for Medical Technology Assessment, Department of Medical and Health Sciences, Linköping University, 581 83, Linköping, Sweden
| |
Collapse
|
40
|
Manes E, Tchetchik A, Tobol Y, Durst R, Chodick G. An Empirical Investigation of "Physician Congestion" in U.S. University Hospitals. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2019; 16:ijerph16050761. [PMID: 30832384 PMCID: PMC6427243 DOI: 10.3390/ijerph16050761] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/05/2018] [Revised: 01/22/2019] [Accepted: 02/26/2019] [Indexed: 01/01/2023]
Abstract
We add a new angle to the debate on whether greater healthcare spending is associated with better outcomes, by focusing on the link between the size of the physician workforce at the ward level and healthcare results. Drawing on standard organization theories, we proposed that due to organizational limitations, the relationship between physician workforce size and medical performance is hump-shaped. Using a sample of 150 U.S. university departments across three specialties that record measures of clinical scores, as well as a rich set of covariates, we found that the relationship was indeed hump-shaped. At the two extremes, departments with an insufficient (excessive) number of physicians may gain a substantial increase in healthcare quality by the addition (dismissal) of a single physician. The marginal elasticity of healthcare quality with respect to the number of physicians, although positive and significant, was much smaller than the marginal contribution of other factors. Moreover, research quality conducted at the ward level was shown to be an important moderator. Our results suggest that studying the relationship between the number of physicians per bed and the quality of healthcare at an aggregate level may lead to bias. Framing the problem at the ward-level may facilitate a better allocation of physicians.
Collapse
Affiliation(s)
- Eran Manes
- The Department of Public Policy and Administration, Ben-Gurion University of the Negev, POB 653, Beer-Sheva 84105, Israel.
- Faculty of Management, Lev College of Technology, Havaad Haleumi 21 St., Givat Mordechai, Jerusalem 9116001, Israel.
| | - Anat Tchetchik
- The Department of Geography and Environment, Bar-Ilan University, Ramat-Gan 5290002, Israel.
| | - Yosef Tobol
- Faculty of Management, Lev College of Technology, Havaad Haleumi 21 St., Givat Mordechai, Jerusalem 9116001, Israel.
- IZA-Institute of Labor Economics Schaumburg-Lippe-Straße 5-9, 53113 Bonn, Germany.
| | - Ronen Durst
- Cardiology Division, Hadassah Hebrew University Medical Center, Ein Kerem, Jerusalem 91120, Israel.
| | - Gabriel Chodick
- School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel.
| |
Collapse
|
41
|
Mueller JT, Park SY, Mowen AJ. The relationship between parks and recreation per capita spending and mortality from 1980 to 2010: A fixed effects model. Prev Med Rep 2019; 14:100827. [PMID: 30815338 PMCID: PMC6377401 DOI: 10.1016/j.pmedr.2019.100827] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2018] [Revised: 01/08/2019] [Accepted: 02/06/2019] [Indexed: 11/26/2022] Open
Abstract
Evidence concerning the link between park access, use, programming and health has continued to grow. However, government funding for parks and recreation is highly susceptible to the ebbs and flows of the national economy. Given this, the purpose of this study was to test the relationship between county area spending on parks and recreation operations and all-cause mortality in the United States from the years 1980–2010. Using data from 1980 to 2010 collected from the U.S. Census Bureau and the Institute for Health Metrics and Evaluation, we analyzed the relationship between per capita county area spending on parks and recreation and county-level all-cause age-standardized female, male, and overall mortality using county and year fixed effects as well as relevant time-variant controls. The study was conducted during 2017 and 2018. County area spending on parks and recreation was negatively associated with overall and female-specific mortality from 1980 to 2010. According to our models for female and overall all-cause age-standardized mortality, when holding all else equal, a hundred-dollar increase in 2010 dollars in per capita parks and recreation operational expenditures was associated with an average decrease in morality of 3.9 and 3.4 deaths per 100,000, respectively. Although not commonly viewed as a form of healthcare spending, increased government funding for parks and recreation services had a significant association with decreased county level mortality. Our results suggest higher levels of per capita spending on parks and recreation may lead to lower levels of mortality. Higher per-capita parks and recreation spending was associated with lower all-cause mortality. The relationship held for female and overall mortality, but not male. Increased parks and recreation spending was associated with decreased mortality. Increasing government spending on parks and recreation may improve public health.
Collapse
Affiliation(s)
- J Tom Mueller
- Department of Agricultural Economics, Sociology, and Education, College of Agricultural Sciences, The Pennsylvania State University, Armsby Building, University Park, PA 16802, United States of America
| | - So Young Park
- Department of Recreation, Park, and Tourism Management, College of Health and Human Development, The Pennsylvania State University, 801 Donald H. Ford Building, University Park, PA 16802, United States of America
| | - Andrew J Mowen
- Department of Recreation, Park, and Tourism Management, College of Health and Human Development, The Pennsylvania State University, 801 Donald H. Ford Building, University Park, PA 16802, United States of America
| |
Collapse
|
42
|
Claxton K, Asaria M, Chansa C, Jamison J, Lomas J, Ochalek J, Paulden M. Accounting for Timing when Assessing Health-Related Policies. JOURNAL OF BENEFIT-COST ANALYSIS 2019; 10:73-105. [PMID: 33282628 PMCID: PMC7691758 DOI: 10.1017/bca.2018.29] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Abstract
The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consumption effects avoids embedding multiple arguments in discounting policies. This helps to identify where parameters are likely to differ in particular contexts, what type of evidence would be relevant, what is currently known and how this evidence might be strengthened. The current evidence available to support the assessment of the key parameters is discussed and possible estimates and default assumptions are suggested. Reporting the results in an extensive way is recommended. This makes the assessments required explicit so the impact of alternative assumptions can be explored and analysis updated as better estimates evolve. Some projects will have effects across different countries where some or all of these parameters will differ. Therefore, the net present value of a project will be the sum of the country specific net present values rather than the sum of effects across countries discounted at some common rate.
Collapse
Affiliation(s)
- Karl Claxton
- The London School of Economics and Political Science (LSE), Amrita Institute of Medical Sciences and Research Centre, London WC2A 2AE, UK, e-mail:
- World Bank Group, Lusaka 10101, Zambia, e-mail:
- University of Exeter Business School, Exeter EX4 4PU, UK, e-mail:
- University of York, Centre for Health Economics, York YO10 5DD, UK, e-mail:
- University of York, Centre for Health Economics York YO10 5DD, UK, e-mail:
- University of Alberta, School of Public Health Edmonton, Alberta T6G 1C9, Canada, e-mail:
| | - Miqdad Asaria
- The London School of Economics and Political Science (LSE), Amrita Institute of Medical Sciences and Research Centre, London WC2A 2AE, UK, e-mail:
| | | | - Julian Jamison
- University of Exeter Business School, Exeter EX4 4PU, UK, e-mail:
| | - James Lomas
- University of York, Centre for Health Economics, York YO10 5DD, UK, e-mail:
| | - Jessica Ochalek
- University of York, Centre for Health Economics York YO10 5DD, UK, e-mail:
| | - Mike Paulden
- University of Alberta, School of Public Health Edmonton, Alberta T6G 1C9, Canada, e-mail:
| |
Collapse
|
43
|
van Baal P, Perry‐Duxbury M, Bakx P, Versteegh M, van Doorslaer E, Brouwer W. A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending. HEALTH ECONOMICS 2019; 28:87-100. [PMID: 30273967 PMCID: PMC6585934 DOI: 10.1002/hec.3831] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/17/2018] [Revised: 06/19/2018] [Accepted: 07/02/2018] [Indexed: 05/17/2023]
Abstract
Traditionally, threshold levels of cost-effectiveness have been derived from willingness-to-pay studies, indicating the consumption value of health (v-thresholds). However, it has been argued that v-thresholds need to be supplemented by so-called k-thresholds, which are based on the marginal returns to health care. The objective of this research is to estimate a k-threshold based on the marginal returns to cardiovascular disease (CVD) hospital care in the Netherlands. To estimate a k-threshold for hospital care on CVD, we proceed in two steps: First, we estimate the impact of hospital spending on mortality using a Bayesian regression modelling framework, using data on CVD mortality and CVD hospital spending by age and gender for the period 1994-2010. Second, we use life tables in combination with quality of life data to convert these estimates into a k-threshold expressed in euros per quality-adjusted life year gained. Our base case estimate resulted in an estimate of 41,000 per quality-adjusted life year gained. In our sensitivity analyses, we illustrated how the incorporation of prior evidence into the estimation pushes estimates downwards. We conclude that our base case estimate of the k-threshold may serve as a benchmark value for decision making in the Netherlands as well as for future research regarding k-thresholds.
Collapse
Affiliation(s)
- Pieter van Baal
- Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
| | - Meg Perry‐Duxbury
- Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
| | - Pieter Bakx
- Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
| | - Matthijs Versteegh
- Institute for Medical Technology AssessmentErasmus University RotterdamRotterdamThe Netherlands
| | - Eddy van Doorslaer
- Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
- Department of Applied EconomicsErasmus School of EconomicsRotterdamThe Netherlands
| | - Werner Brouwer
- Erasmus School of Health Policy and ManagementErasmus University RotterdamRotterdamThe Netherlands
| |
Collapse
|
44
|
Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ Glob Health 2018; 3:e000964. [PMID: 30483412 PMCID: PMC6231096 DOI: 10.1136/bmjgh-2018-000964] [Citation(s) in RCA: 159] [Impact Index Per Article: 26.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2018] [Revised: 09/12/2018] [Accepted: 09/14/2018] [Indexed: 01/24/2023] Open
Abstract
The economic evaluation of healthcare interventions requires an assessment of whether the improvement in health outcomes they offer exceeds the improvement in health that would have been possible if the additional resources required had, instead, been made available for other healthcare activities. Therefore, some assessment of these health opportunity costs is required if the best use is to be made of the resources available for healthcare. This paper provides a framework for generating country-specific estimates of cost per disability-adjusted life year (DALY) averted 'thresholds' that reflect health opportunity costs. We apply estimated elasticities on mortality, survival, morbidity and a generic measure of health, DALYs, that take account of measures of a country's infrastructure and changes in donor funding to country-specific data on health expenditure, epidemiology and demographics to determine the likely DALYs averted from a 1% change in expenditure on health. The resulting range of cost per DALY averted 'threshold' estimates for each country that represent likely health opportunity costs tend to fall below the range previously suggested by WHO of 1-3× gross domestic product (GDP) per capita. The 1-3× GDP range and many other previous and existing recommendations about which interventions are cost-effective are not based on an empirical assessment of the likely health opportunity costs, and as a consequence, the health effects of changes in health expenditure have tended to be underestimated, and there is a risk that interventions regarded as cost-effective reduce rather than improve health outcomes overall.
Collapse
Affiliation(s)
| | - James Lomas
- Centre for Health Economics, University of York, York, UK
| | - Karl Claxton
- Centre for Health Economics, University of York, York, UK
- Department of Economics and Related Studies, University of York, York, UK
| |
Collapse
|
45
|
Muratov S, Lee J, Holbrook A, Costa A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Tarride JE. Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study. BMC Geriatr 2018; 18:262. [PMID: 30382828 PMCID: PMC6211423 DOI: 10.1186/s12877-018-0952-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2018] [Accepted: 10/17/2018] [Indexed: 11/10/2022] Open
Abstract
Background Senior high cost health care users (HCU) are a priority for many governments. Little research has addressed regional variation of HCU incidence and outcomes, especially among incident HCU. This study describes the regional variation in healthcare costs and mortality across Ontario’s health planning districts [Local Health Integration Networks (LHIN)] among senior incident HCU and non-HCU and explores the relationship between healthcare spending and mortality. Methods We conducted a retrospective population-based matched cohort study of incident senior HCU defined as Ontarians aged ≥66 years in the top 5% most costly healthcare users in fiscal year (FY) 2013. We matched HCU to non-HCU (1:3) based on age, sex and LHIN. Primary outcomes were LHIN-based variation in costs (total and 12 cost components) and mortality during FY2013 as measured by variance estimates derived from multi-level models. Outcomes were risk-adjusted for age, sex, ADGs, and low-income status. In a cost-mortality analysis by LHIN, risk-adjusted random effects for total costs and mortality were graphically presented together in a cost-mortality plane to identify low and high performers. Results We studied 175,847 incident HCU and 527,541 matched non-HCU. On average, 94 out of 1000 seniors per LHIN were HCU (CV = 4.6%). The mean total costs for HCU in FY2013 were 12 times higher that of non-HCU ($29,779 vs. $2472 respectively), whereas all-cause mortality was 13.6 times greater (103.9 vs. 7.5 per 1000 seniors). Regional variation in costs and mortality was lower in senior HCU compared with non-HCU. We identified greater variability in accessing the healthcare system, but, once the patient entered the system, variation in costs was low. The traditional drivers of costs and mortality that we adjusted for played little role in driving the observed variation in HCUs’ outcomes. We identified LHINs that had high mortality rates despite elevated healthcare expenditures and those that achieved lower mortality at lower costs. Some LHINs achieved low mortality at excessively high costs. Conclusions Risk-adjusted allocation of healthcare resources to seniors in Ontario is overall similar across health districts, more so for HCU than non-HCU. Identified important variation in the cost-mortality relationship across LHINs needs to be further explored. Electronic supplementary material The online version of this article (10.1186/s12877-018-0952-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Sergei Muratov
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. .,Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare, Hamilton, ON, Canada.
| | - Justin Lee
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.,Division of Geriatric Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada.,Division of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, ON, Canada.,Geriatric Education and Research in Aging Sciences Centre, Hamilton Health Sciences, Hamilton, ON, Canada
| | - Anne Holbrook
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.,Division of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, ON, Canada
| | - Andrew Costa
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.,Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada.,Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada
| | - J Michael Paterson
- Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada.,Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - Jason R Guertin
- Département de Médecine Sociale et Préventive, Faculté de Médecine, Université Laval, Quebec City, QC, Canada.,Centre de recherche du CHU de Québec, Université Laval, Axe Santé des Populations et Pratiques Optimales en Santé, Québec City, QC, Canada
| | - Lawrence Mbuagbaw
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.,Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, ON, Canada
| | - Tara Gomes
- Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada.,Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.,Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada
| | - Wayne Khuu
- Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada
| | - Jean-Eric Tarride
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.,Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare, Hamilton, ON, Canada.,Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada
| |
Collapse
|
46
|
Impact of healthcare insurance on medical expense in China: new evidence from meta-analysis. Soft comput 2018. [DOI: 10.1007/s00500-017-2928-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
47
|
Ahangar A, Ahmadi AM, Mozayani AHM, Dizaji SF. Why Are Risk-Pooling and Risk-Sharing Arrangements Necessary for Financing Healthcare and Improving Health Outcomes in Low and Lower Middle-Income Countries. Health (London) 2018. [DOI: 10.4236/health.2018.101010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|